Browse diseases

…ointestinal involvement. Future studies of these candidates for SSc drug repurposing are indicated; many of which are widely availa…

…Interstitial lung disease (ILD) is a common manifestation of systemic sclerosis (SSc) affecting approximately 50% of patients at diagnosis when…

….27 Table 1Significant clinical characteristics associated with interstitial lung disease (ILD) in systemic sclerosis (SSc) and mixed connective tissue disease…

…ng disease (ILD) is a major cause of morbidity and mortality in systemic sclerosis (SSc), yet its course is highly variable and challenging to predict. …

…Introduction Systemic sclerosis (SSc) is associated with the highest case-related mortality of …

…Introduction In severe refractory SSc, treatments that halt disease progression and improve long-term…

…Introduction Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a progressive fibrotic disorder and a leading cause of morta…

…erum KL-6 levels, and worsening skin fibrosis over two years in SSc patients. These findings suggest that NVC, in combination with …

…Introduction Interstitial lung disease (ILD) is a leading cause of morbidity and mortality in systemic scler…

…-fibrotic and pro-inflammatory cytokine, has been implicated in inflammatory bowel disease and intestinal fibrosis. Experimental evidence implicates TL1A-…

…Introduction Systemic sclerosis (SSc) is a chronic connective tissue disease characterized by inflamm…

…athic inflammatory myopathy (IIM), systemic sclerosis (SSc),and rheumatoid arthritis (RA)-ILD patients who underwent double lung transplant at two C…